Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) andBLA submission anticipated in 1H 2026 Registrational Phase 3 KYV-101 trial in myasthenia gravis (MG) to inclu ...

Financial Results for the Quarter Ended June 30, 2025 Kyverna reported $211.7 million in cash, cash equivalents, and marketable securities as of June 30, 2025, which the Company expects will provide a ...

Linde plc (NASDAQ:LIN) is among the 11 Best Hydrogen Stocks to Invest in Now. Caliche Development Partners has put the ...

From Lord of the Rings to the ramen craze to Ozempic, the cultural touchstones that help us understand the 21st century.

Today, banks are finally publicly voicing their support for crypto, epitomized by JPMorgan Chase CEO Jamie Dimon’s decision to allow Bitcoin trading for clients. With all of the banking system's ...

Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with q ...